Phase III, Double-Blind, Placebo-Controlled Study of Post-Operative Adjuvant Concurrent Chemo-Radiotherapy With or Without Nimotuzumab for Stage III/IV Head and Neck Squamous Cell Cancer.
Phase of Trial: Phase III
Latest Information Update: 02 Apr 2018
At a glance
- Drugs Nimotuzumab (Primary) ; Cisplatin
- Indications Head and neck cancer
- Focus Therapeutic Use
- 01 Nov 2013 Planned end date changed from 1 Jun 2016 to 1 Jun 2021 as reported by ClinicalTrials.gov.
- 30 Aug 2011 Additional lead trial centre and investigator identified as reported by Clinical Trials Registry - India; CTRI2010-091-001230).
- 30 Aug 2011 New source identified and integrated (Clinical Trials Registry - India; CTRI2010-091-001230).